Lorraine O'driscoll
Dublin, L, Ireland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 93 publications
A workflow for assessing antibody-drug conjugate target expression on circulating tumour cells from triple-negative breast cancer and epithelial ovarian cancer patients.
Journal: The journal of liquid biopsy
Published: April 09, 2026
Psychosocial Impact of Sarcoma: Challenges and Adaptation, a Meta-Synthesis.
Journal: Psycho-oncology
Published: March 11, 2026
Size-exclusion chromatography as a clinically applicable method for extracellular vesicles collection as liquid biopsies shows potential diagnostic relevance and correlation with poorer outcome in common cancer types.
Journal: Translational oncology
Published: February 26, 2026
A bibliometric systematic review of extracellular vesicles in cutaneous malignant melanoma from 2005 to 2025.
Journal: Frontiers in oncology
Published: October 23, 2025
Extracellular vesicle-mediated crosstalk in bone: miR-150-5p as a mechanosensitive regulator of osteoclastogenesis.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: August 11, 2025
Circulating tumour cells are a prognostic indicator in advanced high-grade serous ovarian cancer and are associated with platelets and immune cells following dissemination.
Journal: British journal of cancer
Published: April 16, 2025
Correction: miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer.
Journal: Molecular cancer
Published: January 31, 2025
A pilot study evaluating the feasibility of enriching and detecting circulating tumour cells from peripheral and ovarian veins in rare epithelial ovarian carcinomas.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: December 23, 2024
Editorial expression of concern: miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer.
Journal: Molecular cancer
Published: October 01, 2024
Extracellular vesicles and the tumour microenvironment.
Journal: Biochimica et biophysica acta. Reviews on cancer
Published: June 11, 2024
Last Updated: 09/26/2026